RSK2 enzymatic assay as a second level diagnostic tool in Coffin-Lowry syndrome

Vanna Micheli, Sylvia Sestini, Veronica Parri, Marco Fichera, Corrado Romano, Francesca Ariani, Ilaria Longo, Francesca Mari, Mirella Bruttini, Alessandra Renieri, Ilaria Meloni

Research output: Contribution to journalArticle

Abstract

Background: Coffin-Lowry syndrome is a semi-dominant condition characterized by severe psychomotor retardation with facial, hand and skeletal malformations resulting from mutations in RSK2 gene, encoding for a serine/threonine kinase. More than 100 different mutations have been identified to date; however, about 50% of clinically diagnosed patients apparently do not have mutations. In order to exclude that these patients have RSK2 mutations missed by standard mutation detection techniques, a rapid and sensitive assay allowing evaluation of RSK2 activity was needed. Methods: RSK2 capacity to phosphorylate a synthetic CREB-peptide in basal and PMA-stimulated conditions was evaluated in lymphoblasts from 3 patients with RSK2 mutations and normal controls. Results: Patients RSK2 activity is normal in nonstimulated conditions but fails to grow following stimulation. The evaluation of the stimulated/non-stimulated activity ratio demonstrated a statistically significant impairment in patients. Conclusions: We have set up an assay which allows the identification of even partial alterations of RSK2 activity and seems to give good results also in females with a balanced X-chromosome inactivation and thus with a presumably normal enzymatic activity in about 50% of cells. Moreover, our data seem to confirm previous reports of a potential direct correlation between the level of RSK2 activity and the severity of cognitive impairment.

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalClinica Chimica Acta
Volume384
Issue number1-2
DOIs
Publication statusPublished - Sep 2007

Keywords

  • Coffin Lowry syndrome (CLS)
  • diagnostic tool
  • enzymatic assay
  • RSK2 protein

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'RSK2 enzymatic assay as a second level diagnostic tool in Coffin-Lowry syndrome'. Together they form a unique fingerprint.

  • Cite this

    Micheli, V., Sestini, S., Parri, V., Fichera, M., Romano, C., Ariani, F., Longo, I., Mari, F., Bruttini, M., Renieri, A., & Meloni, I. (2007). RSK2 enzymatic assay as a second level diagnostic tool in Coffin-Lowry syndrome. Clinica Chimica Acta, 384(1-2), 35-40. https://doi.org/10.1016/j.cca.2007.05.016